GAIN THERAPEUTICS INC
2.1350
07-October-24 14:59:56
15 minutes delayed
Stocks
+0.3150
+17.31%
Today's range
1.8260 - 2.1400
ISIN
N/A
Source
NASDAQ
-
12 Sep 2023 08:25:00 By Nasdaq GlobeNewswire
-
Gain Therapeutics Announces Second Quarter 2023 Financial Results and Business Update
10 Aug 2023 06:00:01 By Nasdaq GlobeNewswire
-
07 Aug 2023 06:00:00 By Nasdaq GlobeNewswire
-
Gain Therapeutics to Participate in the 2023 BTIG Virtual Biotechnology Conference
31 Jul 2023 07:00:00 By Nasdaq GlobeNewswire
-
Gain Therapeutics to Present at the Jefferies Healthcare Conference
01 Jun 2023 07:00:01 By Nasdaq GlobeNewswire
-
Gain Therapeutics Reports First Quarter 2023 Financial Results and Business Update
12 May 2023 07:00:00 By Nasdaq GlobeNewswire
-
03 May 2023 08:15:00 By Nasdaq GlobeNewswire
-
Gain Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer
12 Apr 2023 15:30:00 By Nasdaq GlobeNewswire
-
Gain Therapeutics to Present Positive Preclinical Data on its GBA1 Program at the AD/PD 2023 Meeting
29 Mar 2023 07:52:52 By Nasdaq GlobeNewswire
-
Gain Therapeutics Reports Full Year 2022 Financial Results and Business Update
23 Mar 2023 15:05:00 By Nasdaq GlobeNewswire
-
22 Mar 2023 07:30:00 By Nasdaq GlobeNewswire
-
21 Mar 2023 07:00:01 By Nasdaq GlobeNewswire
-
Gain Therapeutics to Participate in the Oppenheimer 33rd Annual Healthcare Conference
09 Mar 2023 07:00:03 By Nasdaq GlobeNewswire
-
27 Feb 2023 07:00:01 By Nasdaq GlobeNewswire
-
Gain Therapeutics to Participate in Upcoming Scientific and Medical Conferences
02 Feb 2023 07:00:00 By Nasdaq GlobeNewswire
-
Gain Therapeutics to Present at Sidoti Small-Cap Virtual Investor Conference
12 Jan 2023 15:05:00 By Nasdaq GlobeNewswire
-
Gain Therapeutics, Inc. Reports Third Quarter 2022 Financial Results and Business Update
10 Nov 2022 15:02:00 By Nasdaq GlobeNewswire
-
26 Sep 2022 07:00:02 By Nasdaq GlobeNewswire
-
Gain Therapeutics Announces Promotion of Matthias Alder to Chief Executive Officer
20 Sep 2022 06:30:00 By Nasdaq GlobeNewswire